Abstract
Cytogenetic effects of ciprofloxacin (500 to 2,000 mg daily) and ofloxacin (200 mg daily) were studied in lymphocytes from 31 patients treated for 1 to 10 weeks. Blood samples for cytogenetic analysis were taken before the start of treatment from all patients, after 1 week from 25 patients, and after 2, 4, 6, and 10 weeks from six patients. No chromosome-damaging effect could be demonstrated in any treatment group. The mean aberration yields for each cytogenetic parameter studied and the total number of aberrations were all normal at each sampling occasion.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Forsgren A., Bergh A. K., Brandt M., Hansson G. Quinolones affect thymidine incorporation into the DNA of human lymphocytes. Antimicrob Agents Chemother. 1986 Mar;29(3):506–508. doi: 10.1128/aac.29.3.506. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Forsgren A., Bredberg A., Pardee A. B., Schlossman S. F., Tedder T. F. Effects of ciprofloxacin on eucaryotic pyrimidine nucleotide biosynthesis and cell growth. Antimicrob Agents Chemother. 1987 May;31(5):774–779. doi: 10.1128/aac.31.5.774. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Forsgren A., Schlossman S. F., Tedder T. F. 4-Quinolone drugs affect cell cycle progression and function of human lymphocytes in vitro. Antimicrob Agents Chemother. 1987 May;31(5):768–773. doi: 10.1128/aac.31.5.768. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hedner K., Högstedt B., Kolnig A. M., Mark-Vendel E., Strömbeck B., Mitelman F. Relationship between sister chromatid exchanges and structural chromosome aberrations in lymphocytes of 100 individuals. Hereditas. 1982;97(2):237–245. doi: 10.1111/j.1601-5223.1982.tb00768.x. [DOI] [PubMed] [Google Scholar]
- Hedner K., Kolnig A. M., Strömbeck B., Nordén A., Mitelman F. A twin study of structural chromosome aberrations in lymphocytes. Cytogenet Cell Genet. 1986;41(1):58–59. doi: 10.1159/000132198. [DOI] [PubMed] [Google Scholar]
- Högstedt B., Gullberg B., Hedner K., Kolnig A. M., Mitelman F., Skerfving S., Widegren B. Chromosome aberrations and micronuclei in bone marrow cells and peripheral blood lymphocytes in humans exposed to ethylene oxide. Hereditas. 1983;98(1):105–113. doi: 10.1111/j.1601-5223.1983.tb00585.x. [DOI] [PubMed] [Google Scholar]
- Mitelman F., Strömbeck B., Ursing B., Nordle O., Hartley-Asp B. Metronidazole exhibits no clastogenic activity in a double-blind cross-over study on Crohn's patients. Hereditas. 1982;96(2):279–286. doi: 10.1111/j.1601-5223.1982.tb00859.x. [DOI] [PubMed] [Google Scholar]
- Shen L. L., Pernet A. G. Mechanism of inhibition of DNA gyrase by analogues of nalidixic acid: the target of the drugs is DNA. Proc Natl Acad Sci U S A. 1985 Jan;82(2):307–311. doi: 10.1073/pnas.82.2.307. [DOI] [PMC free article] [PubMed] [Google Scholar]